pharmaceutical industry

Drug companies to collaborate on Alzheimer's disease

The rising cost of development and research is making drug companies turn to each other for help. Rival companies that include Pfizer, AstraZeneca, and Roche plan on sharing clinical data in a standard format. But this isn't the first time we've seen pharmaceutical companies start to share data.

» Read more

0 Comments

Open pharmaceutical innovation

When it comes to infectious diseases, sharing is generally discouraged. But recently, pharmaceutical giant GlaxoSmithKline (GSK) opened up the designs behind 13,500 chemical compounds, which the company narrowed down from over two million, that may be capable of fighting malaria.

The process of determing which compounds could yield a malaria drug is time consuming and complex, but GSK hopes to inspire other researchers to pool their intellectual property and work together to develop new and better medicines to fight the diseases that are rampant in the world’s poorest countries. » Read more

1 Comment

GlaxoSmithKline announces open innovation plans

Forbes reports that pharmaceutical giant GlaxoSmithKline announced a plan to beginning collaborating with other companies on research into drugs for diseases that don't get a lot of attention, malaria being a key example. It sounds like open innovation in action. Read the Forbes article here, but here's a key quote: » Read more

2 Comments